Professor Quirke's YCR Quinquennial review has doubled his grant from 577K to 1.156M.
The MRC Focus 3 trial will start in January 2010 . This is run jointly with Cardiff University. Professor Seymour, Professor Quirke and Dr Grabsch are co-investigators.
Pathology has been shortlisted for the 1.85M MRC Pathology training programme
Dr Deborah Holliday presented her work on 3D breast cancer models at the recent NC3Rs event at the House of Lords and won the prize for 'replacement of animal experiments'. Judging criteria was on scientific quality, ability to communicate to a lay audience and impact on the 3Rs.
Digital Pathology: Darren Treanor and Phil Quirke, along with Drs Ruddle, Magee and Bulpitt were awarded £600K from NIHR to investigate new improved methods of visualising digital slides including powerwalls.
A YCR Fellowship has been awarded to Walport Academic Clinical Fellow Dr Nick West.
Laura Smith, a postdoctoral research fellow in the Gene Regulation & Cancer Group (Group Leader - Tom Hughes) in the Section of Pathology , was awarded a prize for her talk at the Biochemical Society meeting on 'Gene Expression & Analysis' in March 2008. The talk was entitled 'Estrogen receptor beta expression is regulated by alternative 5 'UTRs'
Over the past 12 months research grants were awarded to the breast group by Cancer Research UK, Breast Cancer Research Trust, The Pathological Society Yorkshire Cancer Research and we are grateful to the continued support of the Breast Cancer Research Action Group. The group also received funding from Breast Cancer Campaign to take forward a study on male breast cancer, which will be one of the largest of its kind ever conducted.
Mr Loaie Maraqa, a MD student supervised by Dr Valerie Speirs of the Breast Cancer Research group, won the British Journal of Surgery Prize at the British Association of Surgical Oncology (BASO) for a presentation entitled "CEACAM6 is a powerful prognostic marker of breast cancer recurrence". This work was published in Clinical Cancer Research in January 2008 under the title 'CEACAM6 predicts breast cancer recurrence following adjuvant tamoxifen'.
Helen Honarpisheh, supervised by Dr Valerie Speirs and Dr Abeer Shaaban, was awarded an MSc in February 2008 following a research project on male breast cancer.
Dr Valerie Speirs was awarded FRCPath by published works in 2007.